Tag: CorMedix

FB Nasdaq FB Facebook
Finance

Biotech Bearish Stocks: Celsus Therapeutics (NASDAQ:CLTX), Reliv International (NASDAQ:RELV), Fate Therapeutics Inc (NASDAQ:FATE), CorMedix Inc. (NYSEMKT:CRMD)

Celsus Therapeutics PLC (ADR) (NASDAQ:CLTX) major shareholder Sabby Management, Llc acquired 16,203 shares of Celsus Therapeutics PLC stock in a transaction dated Thursday, March 27th. The shares were purchased at an average price of $6.66 per share, for a total transaction of $107,911.98. Celsus Therapeutics PLC (ADR) (NASDAQ:CLTX) stock performance was -5.24% in last session and finished the day at $6.15. Traded volume was 35.9K … Continue reading Biotech Bearish Stocks: Celsus Therapeutics (NASDAQ:CLTX), Reliv International (NASDAQ:RELV), Fate Therapeutics Inc (NASDAQ:FATE), CorMedix Inc. (NYSEMKT:CRMD)

John Meady
Finance

Biotech Most Volatile: Cara Therapeutics Inc (NASDAQ:CARA), Prothena Corporation (NASDAQ:PRTA), CorMedix Inc. (NYSEMKT:CRMD), Stemline Therapeutics (NASDAQ:STML)

Cara Therapeutics Inc (NASDAQ:CARA) posted its quarterly earnings results on Thursday. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by $0.31. Cara Therapeutics Inc (NASDAQ:CARA) stock performance was 3.44% in last session and finished the day at $19.25. Traded volume was 234.6K shares in the last session and the average volume of the stock remained 298.33K … Continue reading Biotech Most Volatile: Cara Therapeutics Inc (NASDAQ:CARA), Prothena Corporation (NASDAQ:PRTA), CorMedix Inc. (NYSEMKT:CRMD), Stemline Therapeutics (NASDAQ:STML)

John Bellich
Finance

Healthcare Decliners: Escalon Medical (NASDAQ:ESMC), CorMedix Inc. (NYSEMKT:CRMD), Ocera Therapeutics Inc (NASDAQ:OCRX), Marina Biotech (OTCMKTS:MRNA)

Escalon Medical Corp. (NASDAQ:ESMC) trades at a significant discount to its peer group as the lack of investor (and analyst) following results in the successful “shrink to grow” strategy being ignored. The company is now a pure play with no debt, cash that represents ~20% of the market cap, overlooked tax assets and a significantly lower cash burn rate. Escalon Medical Corp. (NASDAQ:ESMC) stock performance … Continue reading Healthcare Decliners: Escalon Medical (NASDAQ:ESMC), CorMedix Inc. (NYSEMKT:CRMD), Ocera Therapeutics Inc (NASDAQ:OCRX), Marina Biotech (OTCMKTS:MRNA)

Richard Atkins
Finance

Biotech Decliners: Ocera Therapeutics Inc (NASDAQ:OCRX), Marina Biotech, Inc. (OTCMKTS:MRNA), CorMedix Inc. (NYSEMKT:CRMD), Idera Pharmaceuticals Inc (NASDAQ:IDRA)

Ocera Therapeutics Inc (NASDAQ:OCRX) is a company with one main value driver, OCR002. Financially, the company is now sitting on $47.2 M and will be spending $30M in the 2014 financial year. It has about one year in cash. Last year, it spent $3.5M in R&D and these costs are set to increase as it ramps up the Phase 2 trials for OCR002. Ocera Therapeutics … Continue reading Biotech Decliners: Ocera Therapeutics Inc (NASDAQ:OCRX), Marina Biotech, Inc. (OTCMKTS:MRNA), CorMedix Inc. (NYSEMKT:CRMD), Idera Pharmaceuticals Inc (NASDAQ:IDRA)

John Meady
Finance

Today’s Watch List : Annaly Capital Management (NYSE:NLY), ChinaNet Online (NASDAQ:CNET), Alamo Group, Inc. (NYSE:ALG), Wal-Mart Stores Inc. (NYSE:WMT), CorMedix, Inc. (NYSEMKT:CRMD),

Citigroup Inc. reiterated their neutral rating on shares of Annaly Capital Management (NYSE:NLY) in a research report released on Friday morning. Citigroup Inc. currently has a $11.00 price objective on the stock, up from their previous price objective of $10.00. Annaly Capital Management, Inc. (NYSE:NLY) belongs to Financial sector. Its net profit margin is 42.50% and weekly performance is -0.62%. On last trading day company … Continue reading Today’s Watch List : Annaly Capital Management (NYSE:NLY), ChinaNet Online (NASDAQ:CNET), Alamo Group, Inc. (NYSE:ALG), Wal-Mart Stores Inc. (NYSE:WMT), CorMedix, Inc. (NYSEMKT:CRMD),

Mark Doerr